| Literature DB >> 34264867 |
Wen Meng1, Ting Xiao1, Xiuci Liang1, Jie Wen1,2, Xinyi Peng1,2, Jing Wang1, Yi Zou3, Jiahao Liu1, Christie Bialowas4, Hairong Luo1, Yacheng Zhang1,5, Bilian Liu1, Jingjing Zhang1, Fang Hu1, Meilian Liu1,6, Lily Q Dong7, Zhiguang Zhou1, Feng Liu1,2, Juli Bai1,2.
Abstract
A dynamically regulated microenvironment, which is mediated by crosstalk between adipocytes and neighboring cells, is critical for adipose tissue homeostasis and function. However, information on key molecules and/or signaling pathways regulating the crosstalk remains limited. In this study, we identify adipocyte miRNA-182-5p (miR-182-5p) as a crucial antiobesity molecule that stimulated beige fat thermogenesis by promoting the crosstalk between adipocytes and macrophages. miR-182-5p was highly enriched in thermogenic adipocytes, and its expression was markedly stimulated by cold exposure in mice. In contrast, miR-182-5p expression was significantly reduced in adipose tissues of obese humans and mice. Knockout of miR-185-5p decreased cold-induced beige fat thermogenesis whereas overexpression of miR-185-5p increased beiging and thermogenesis in mice. Mechanistically, miR-182-5p promoted FGF21 expression and secretion in adipocytes by suppressing nuclear receptor subfamily 1 group D member 1 (Nr1d1) at 5'-UTR, which in turn stimulates acetylcholine synthesis and release in macrophages. Increased acetylcholine expression activated the nicotine acetylcholine receptor in adipocytes, which stimulated PKA signaling and consequent thermogenic gene expression. Our study reveals a key role of the miR-182-5p/FGF21/acetylcholine/acetylcholine receptor axis that mediates the crosstalk between adipocytes and macrophages to promote beige fat thermogenesis. Activation of the miR-182-5p-induced signaling pathway in adipose tissue may be an effective approach to ameliorate obesity and associated metabolic diseases.Entities:
Keywords: Adipose tissue; Cellular immune response; Endocrinology; Metabolism; Obesity
Mesh:
Substances:
Year: 2021 PMID: 34264867 PMCID: PMC8492300 DOI: 10.1172/jci.insight.150249
Source DB: PubMed Journal: JCI Insight ISSN: 2379-3708
Figure 1Adipose miR-182-5p expression is negatively correlated with obesity in mice and humans and is stimulated by cold exposure in mice.
(A and B) The relative levels of miR-182-5p in sWAT or BAT of C57BL/6 mice maintained at 25°C (room temperature, RT) or exposed to 4°C for 1 week. (n = 6/group.) (C) Expression levels of miR-182-5p in sWAT of C57BL/6 mice fed with HFD or normal diet for 16 weeks (n = 5/group). (D) Expression levels of miR-182-5p in sWAT of ob/ob and WT mice (n = 4/group). (E) Regression analysis of miR-182-5p expression data from sWAT of human subjects with different BMIs. (F) Relative miR-182-5p expression from subcutaneous fat from nonobese (BMI < 30) and obese (BMI ≥ 30) human subjects. Data represent mean ± SEM. Significance determined by unpaired 2-tailed Student’s t test. *P < 0.05; **P < 0.01.
Figure 2miR-182-5p is a key regulator of thermogenic gene expression and energy expenditure in mice.
Male miR-182-5p heterozygous knockout mice (miR-182-5p+/–) and their WT littermates (8 weeks old) were housed individually in cages and exposed to cold (4°C; 6 h/d) for 7 days. (A) The protein levels of PGC1α, C/EBPβ, and UCP1 in sWAT were determined by Western blot (n = 3/group). (B) Immunohistochemical staining of UCP1 in sWAT of the miR-182-5p+/– mice and WT control mice (n = 3/group; scale bar: 100 μm). (C) miR-182-5p+/– mice and WT control mice (n = 5–7/group) (8 weeks old) were given an intraperitoneal injection of 1 mg/kg norepinephrine (NE) 1 hour, and O2 consumption was measured by Comprehensive Lab Animal Monitoring System (CLAMS) after NE injection. (D) O2 consumptions of miR-182-5p agomir- or control agomir-injected (fat pad) mice (n = 4/group) (8 weeks old) were measured by indirect calorimetry using CLAMS. (E) Mean O2 consumption was normalized to lean body mass and analyzed by Student’s t test. (F) OCR of sWAT of miR-182-5p agomir- or negative control (nc) agomir-injected (fat pad) mice (n = 3/group). Volume O2 consumption was normalized to 10 g tissue weight. (G) The relative mRNA level of Ucp1 in the miR-182-5p agomir- or nc agomir-injected fat pad were determined by quantitative real-time PCR (qRT-PCR) (n = 6/group). (H) The expression of UCP1 protein in mouse fat pad injected with miR-182-5p agomir- or negative control (nc) agomir was determined by Western blot (n = 3/group). (I) Immunohistochemical staining of UCP1 in sWAT of the miR-182-5p agomir- or nc agomir-injected (fat pad) mice (n = 3/group; scale bar: 100 μm). Data represent mean ± SEM. Significance determined by unpaired 2-tailed Student’s t test. *P < 0.05; **P < 0.01.
Figure 3miR-182-5p promotes thermogenic gene expression in adipocytes via a macrophage-dependent mechanism.
(A) qRT-PCR analysis of mRNA levels of M1 and M2 marker genes in sWAT of miR-182-5p agomir- or control agomir-injected (fat pad) mice (n = 4–6/group). (B) Flow cytometry analysis showing the percentage of total stromal vascular fractions (SVFs), and M1 and M2 macrophages in sWAT of miR-182-5p agomir- or control agomir-injected (fat pad) mice (n = 4–5/group). qRT-PCR analysis for mRNA levels of M1 and M2 marker genes (C) and flow cytometry analysis showing the percentage of M1 and M2 macrophages in SVFs (D) from sWAT of miR-182-5p+/– and WT control mice under cold exposure conditions (n = 3–4/group). miR-182-5p mimic (182-mimic) or its negative control (nc-mimic) were overexpressed in mouse primary adipocytes. The cells were cultured alone or cocultured with mouse peritoneal macrophages (PM) for 3 days (n = 3–4/group). (E) The Ucp1 mRNA levels were determined in mouse primary adipocytes by qRT-PCR. (F) qRT-PCR analysis for mRNA levels of M1 and M2 marker genes. Data represent mean ± SEM. Significance determined by unpaired 2-tailed Student’s t test (A–D and F) and by 1-way ANOVA (E). *P < 0.05; **P < 0.01.
Figure 4FGF21 mediates the promotive effect of miR-182-5p on UCP1 expression in adipocytes via a macrophage-dependent mechanism.
(A) INOH pathway analysis of the RNA-Seq data from primary adipocytes overexpressing miR-182-5p (n = 3/group). (B) Heatmap analysis shows the relative expression levels of secretory genes. (C) The Venn diagram showing the strategy to identify thermogenesis-related secretory factors. Volcano plot depicting the gene expression differences between miR-182-5p intervention and control group. Upregulated genes were colored in red, and downregulated genes were colored in blue. (D) FGF21 mRNA and (E) protein levels in primary adipocytes overexpressing miR-182-5p mimic (182-mimic) or its negative control (nc-mimic) were determined by qRT-PCR (n = 3/group) or Western blot, respectively. (F) FGF21 mRNA and (G) protein levels in sWAT of miR-182-5p agomir- or nc-agomir–injected (fat pad) mice (n = 5–6/group) were determined by qRT-PCR or ELISA, respectively. (H) qRT-PCR analysis for FGF21 mRNA levels and (I) ELISA analysis for FGF21 protein concentration in sWAT of miR-182-5p+/–and WT control mice exposed to cold (n = 3–4/group). (J) PMs were treated with or without FGF21 (50 nM) for 48 hours, and conditioned medium (CM) of the cells was collected. Primary adipocytes were incubated with the FGF21-treated (+) or nontreated (-) CM or directly treated with FGF21 for 3 days. UCP1 expression in cells was determined by Western blot analysis (n = 3 biological replicates). 182-mimic or nc-mimic was overexpressed in primary white adipocytes isolated from FGF21KO and their control mice. The cells were cocultured with PMs for 3 days, and the mRNA levels of (K) Arg1 and (L) UCP1 were determined by qRT-PCR (n = 4/group). Data represent mean ± SEM. Significance determined by unpaired 2-tailed Student’s t test (D and F–I) and by 1-way ANOVA (K and L). *P < 0.05; **P < 0.01.
Figure 5miR-182-5p promotes PKA activation via the nAChR signaling pathway.
PKA substrate phosphorylation (A) in sWAT of mice injected with miR-182-5p agomir or control agomir, (B) in sWAT of miR-182-5p+/– and WT control mice, and (C) in miR-182-5p–overexpressed primary adipocytes cocultured with or without PMs (n = 3/group). Choline acetyltransferase (Chat) mRNA levels were determined by qRT-PCR in (D) SVFs and (E) PM treated with or without FGF21 (n = 3–4/group). (F) Chat mRNA levels in sWAT of mice injected with miR-182-5p agomir- or control agomir. ELISA analysis of acetylcholine levels secreted from the (G) sWAT and (H) inguinal SVF of mice injected with miR-182-5p agomir or control agomir (n = 4/group). (I) Chat mRNA levels in PMs cocultured with primary white adipocytes overexpressing 182-mimic or nc-mimic were determined by qRT-PCR (n = 3/group). (J) Chat mRNA levels in βKlotho-siRNA or nc-siRNA–treated PMs cocultured with primary white adipocytes overexpressing miR-182-5p mimic were determined by qRT-PCR (n = 3/group). (K) UCP1 protein levels in sWAT of βKlothomKO mice and Loxp control mice injected with miR-182-5p agomir (-182) or control agomir (-nc) (n = 4/group). The mRNA (L) and protein (M) levels of UCP1 or PKA substrate phosphorylation (M) in primary adipocytes incubated with CM from control (nc-siRNA) or βKlotho-suppressed PMs treated with or without FGF21 were determined by qRT-PCR or Western blot (n = 3 biological replicates). The mRNA (N) and protein (O) levels of UCP1 or PKA substrate phosphorylation (O) in Chrna2-siRNA– or nc-siRNA–treated primary adipocytes incubated with CM from FGF21-treated or nontreated PMs were determined by qRT-PCR or Western blot (n = 3 biological replicates). Data represent mean ± SEM. Significance determined by unpaired 2-tailed Student’s t test (D–J) and by 1-way ANOVA (L and N). *P < 0.05; **P < 0.01.
Figure 6miR-182-5p overexpression in subcutaneous fat pad of mice resists obesity and its metabolic consequences.
C57BL/6 mice were fed HFD for 8 weeks and then received subcutaneous fat pad injection of miR-182-5p agomir or control agomir (nc-agomir) every 3 days for 8 injections. (A) Representative images of miR-182-5p agomir and nc-agomir mice after a 17-week HFD feeding. (B) Body weight (BW) of miR-182-5p agomir and nc-agomir mice fed with HFD for 17 weeks (n = 4/group). (C) Body composition of HFD-fed miR-182-5p agomir and nc-agomir mice (n = 4/group). (D) Representative images of fat pads from HFD-fed miR-182-5p agomir and nc-agomir mice. (E) Weights of sWAT, eWAT, and BAT of HFD-fed miR-182-5p agomir and nc-agomir mice (n = 4/group). (F) Representative images of hematoxylin and eosin staining of sWAT, eWAT, BAT, and liver sections from HFD-fed miR-182-5p agomir and nc-agomir mice (n = 3 biological replicates; scale bar: 100 μm). Glucose tolerance tests (G) and insulin tolerance tests (H) were performed in HFD-fed miR-182-5p agomir and nc-agomir mice (n = 4–5/group) according to similar procedures as described in our previous studies (32). (I) mRNA levels of thermogenic marker genes in sWAT of HFD-fed miR-182-5p agomir and nc-agomir mice were quantified by qRT-PCR and normalized to β-actin (n = 6/group). (J) A proposed model of the mechanism by which miR-182-5p promotes thermogenic gene expression in white adipocytes. Data represent mean ± SEM. Significance determined by unpaired 2-tailed Student’s t test. *P < 0.05; **P < 0.01.